(Q54563052)

1 June 2018

title

Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4. (English)

1 reference

1 June 2018

1 reference

Y-H Chang

1

1 reference

1 June 2018

K-T Ho

2

1 reference

1 June 2018

S-H Lu

3

1 reference

1 June 2018

C-N Huang

4

1 reference

1 June 2018

M-Y Shiau

5

1 reference

1 June 2018

language of work or name

English

0 references

publication date

6 September 2011

1 reference

1 June 2018

International Journal of Obesity

published in

1 reference

1 June 2018

volume

36

1 reference

1 June 2018

issue

7

1 reference

1 June 2018

page(s)

993-998

1 reference

1 June 2018

Insulin resistance as the core defect in type 2 diabetes mellitus

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Disease model: hyperinsulinemia and insulin resistance. Part A-targeted disruption of insulin signaling or glucose transport

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Insulin resistance and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Type 2 diabetes mellitus: a disease of the innate immune system? An update

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Inflammation: the link between insulin resistance, obesity and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

IKK-beta links inflammation to obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Is type II diabetes mellitus a disease of the innate immune system?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Obesity-induced inflammatory changes in adipose tissue.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Inflammation and metabolic disorders

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Role of IRS-2 in insulin and cytokine signalling

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Insulin receptor substrate-2-dependent interleukin-4 signaling in macrophages is impaired in two models of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Association of interleukin-4 promoter polymorphisms in Taiwanese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Nongenetic mouse models of non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Development and application of rodent models for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

The immunology of susceptibility and resistance to Leishmania major in mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Interleukin-6 induces cellular insulin resistance in hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Interleukin-6 depletion selectively improves hepatic insulin action in obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

A stress signaling pathway in adipose tissue regulates hepatic insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Gene expression profile in interleukin-4-stimulated human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Cell metabolism in the regulation of programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Growth factors can influence cell growth and survival through effects on glucose metabolism

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

PKCzeta-regulated inflammation in the nonhematopoietic compartment is critical for obesity-induced glucose intolerance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Crosstalk between PKCzeta and the IL4/Stat6 pathway during T-cell-mediated hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Control of T helper 2 cell function and allergic airway inflammation by PKCzeta

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

High-fat diet delays and fasting advances the circadian expression of adiponectin signaling components in mouse liver

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Leptin modulates the inflammatory response in acute pancreatitis.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Overexpression of IL-4 alters the homeostasis in the skin

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.168

7 January 2021

Identifiers

DOI

10.1038/IJO.2011.168

1 reference

1 June 2018

1 reference

1 June 2018